— Know what they know.
Not Investment Advice
Also trades as: BOI.PA (PAR) · $vol 0M · 0DTF.L (LSE) · $vol 0M

BOIRF OTC

Boiron S.A.
1W: +0.0% 1M: +0.0% 3M: -1.2% YTD: +5.0% 1Y: +10.5% 3Y: +0.2% 5Y: -2.2%
$31.50
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $546.9M mcap · 3M float · 0.0003% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$40M -13.1% ▼
5Y CAGR: -4.9%
Capital Expenditures
$16M +11.6% ▲
5Y CAGR: -15.7%
Free Cash Flow
$24M -14.1% ▼
5Y CAGR: +12.1%
Dividends Paid
$23M +88.2% ▲
Buybacks
$206K -68.9% ▼
Net Change in Cash
-$8M +95.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$26M$29M$45M$36M$11M
Depreciation & Amort.$69M$18M$17M$26M$42M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$15M-$23M$7M$5M-$9M
Other Non-Cash Items-$12M$10M-$10M-$21M-$5M
Operating Cash Flow$68M$33M$59M$45M$40M
— Investing Activities —
Capital Expenditures-$21M-$20M-$19M-$10M-$8M
Acquisitions (Net)-$53K$9M-$2M$0-$977K
Investment Purchases-$453K-$2M-$3M-$7M-$2M
Investment Sales$94K$84K$439K$89K$736K
Other Investing$2M$920K$8M-$6M-$8M
Investing Cash Flow-$19M-$12M-$15M-$23M-$18M
— Financing Activities —
Net Debt Issuance-$3M-$6M-$6M-$5M-$1M
Stock Repurchased-$4K-$12K-$6M-$122K-$206K
Dividends Paid-$18M-$17M-$17M-$199M-$23M
Other Financing$110K$229K$851K$6M-$3M
Financing Cash Flow-$22M-$22M-$28M-$198M-$28M
Net Change in Cash$26M-$231K$16M-$178M-$8M
Cash End of Period$234M$234M$250M$72M$64M
Free Cash Flow$48M$13M$40M$27M$24M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms